Caricamento...
Allogeneic Stem Cell Transplantation for CML Resistant to Tyrosine Kinase Inhibitors
Allogeneic hematopoietic stem cell transplantation (HSCT) is well established as a potentially curative treatment for patients with CML. The success of imatinib and other tyrosine kinase inhibitors (TKI) as initial therapy has changed the treatment paradigm in this disease. Allogeneic hematopoietic...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3226776/ https://ncbi.nlm.nih.gov/pubmed/22035758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2011.03.028 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|